[en] BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a severe inflammatory condition driven by excessive CD8(+) T-cell activation. HLH occurs as both acquired and familial hemophagocytic lymphohistiocytosis (FHL) forms. In both conditions, a sterile or infectious trigger is required for disease initiation, which then becomes self-sustaining and life-threatening. Recent studies have attributed the key distal event to excessive IFN-gamma production; however, the proximal events driving immune dysregulation have remained undefined. OBJECTIVE: We sought to investigate the role of regulatory T (Treg) cells in the pathophysiology of experimental FHL. METHODS: Because mutation in perforin is a common cause of FHL, we used an experimental FHL mouse model in which disease in perforin-deficient mice is triggered by lymphocytic choriomeningitis virus (LCMV). We assessed Treg and CD8(+) T-cell homeostasis and activation during the changing systemic conditions in the mice. In addition, human blood samples were collected and analyzed during the HLH episode. RESULTS: We found no primary Treg cell defects in perforin-deficient mice. However, Treg cell numbers collapsed after LCMV inoculation. The collapse of Treg cell numbers in LCMV-triggered perforin-deficient, but not wild-type, mice was accompanied by the combination of lower IL-2 secretion by conventional CD4(+) T cells, increased IL-2 consumption by activated CD8(+) T cells, and secretion of competitive soluble CD25. Moreover low Treg cell numbers were observed in untreated patients experiencing HLH flares. CONCLUSION: These results demonstrate that excessive CD8(+) T-cell activation rewires the IL-2 homeostatic network away from Treg cell maintenance and toward feed-forward inflammation. These results also provide a potential mechanistic pathway for the progression of infectious inflammation to persistent inflammation in patients with HLH.
1 Janka, G.E., Lehmberg, K., Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematology Am Soc Hematol Educ Program 2013 (2013), 605–611.
2 Usmani, G.N., Woda, B.A., Newburger, P.E., Advances in understanding the pathogenesis of HLH. Br J Haematol 161 (2013), 609–622.
3 Jordan, M.B., Allen, C.E., Weitzman, S., Filipovich, A.H., McClain, K.L., How I treat hemophagocytic lymphohistiocytosis. Blood 118 (2011), 4041–4052.
4 Jordan, M.B., Hildeman, D., Kappler, J., Marrack, P., An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood 104 (2004), 735–743.
5 Sepulveda, F.E., Debeurme, F., Menasche, G., Kurowska, M., Cote, M., Pachlopnik Schmid, J., et al. Distinct severity of HLH in both human and murine mutants with complete loss of cytotoxic effector PRF1, RAB27A, and STX11. Blood 121 (2013), 595–603.
6 Terrell, C.E., Jordan, M.B., Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells. Blood 121 (2013), 5184–5191.
7 Malloy, C.A., Polinski, C., Alkan, S., Manera, R., Challapalli, M., Hemophagocytic lymphohistiocytosis presenting with nonimmune hydrops fetalis. J Perinatol 24 (2004), 458–460.
8 Nitta, A., Suzumura, H., Watabe, Y., Okuya, M., Nakajima, D., Kurosawa, H., et al. Fetal hemophagocytic lymphohistiocytosis in a premature infant. J Pediatr, 151, 2007, 98.
10 Humblet-Baron, S., Sather, B., Anover, S., Becker-Herman, S., Kasprowicz, D.J., Khim, S., et al. Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis. J Clin Invest 117 (2007), 407–418.
11 Miyara, M., Gorochov, G., Ehrenstein, M., Musset, L., Sakaguchi, S., Amoura, Z., Human FoxP3+ regulatory T cells in systemic autoimmune diseases. Autoimmun Rev 10 (2011), 744–755.
12 Schlenner, S.M., Madan, V., Busch, K., Tietz, A., Laufle, C., Costa, C., et al. Fate mapping reveals separate origins of T cells and myeloid lineages in the thymus. Immunity 32 (2010), 426–436.
13 Vikstrom, I., Carotta, S., Luthje, K., Peperzak, V., Jost, P.J., Glaser, S., et al. Mcl-1 is essential for germinal center formation and B cell memory. Science 330 (2010), 1095–1099.
14 Utzschneider, D.T., Legat, A., Fuertes Marraco, S.A., Carrie, L., Luescher, I., Speiser, D.E., et al. T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion. Nat Immunol 14 (2013), 603–610.
15 Butz, E.A., Bevan, M.J., Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity 8 (1998), 167–175.
16 Tian, L., Humblet-Baron, S., Liston, A., Immune tolerance: are regulatory T cell subsets needed to explain suppression of autoimmunity?. Bioessays 34 (2012), 569–575.
17 Fontenot, J.D., Rasmussen, J.P., Gavin, M.A., Rudensky, A.Y., A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6 (2005), 1142–1151.
18 Sharma, R., Sung, S.S., Abaya, C.E., Ju, A.C., Fu, S.M., Ju, S.T., IL-2 regulates CD103 expression on CD4+ T cells in Scurfy mice that display both CD103-dependent and independent inflammation. J Immunol 183 (2009), 1065–1073.
19 Pierson, W., Cauwe, B., Policheni, A., Schlenner, S.M., Franckaert, D., Berges, J., et al. Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3(+) regulatory T cells. Nat Immunol 14 (2013), 959–965.
20 Amado, I.F., Berges, J., Luther, R.J., Mailhe, M.P., Garcia, S., Bandeira, A., et al. IL-2 coordinates IL-2-producing and regulatory T cell interplay. J Exp Med 210 (2013), 2707–2720.
21 Malek, T.R., Castro, I., Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity 33 (2010), 153–165.
23 Vignali, D.A., Collison, L.W., Workman, C.J., How regulatory T cells work. Nat Rev Immunol 8 (2008), 523–532.
24 Russell, S.E., Moore, A.C., Fallon, P.G., Walsh, P.T., Soluble IL-2Ralpha (sCD25) exacerbates autoimmunity and enhances the development of Th17 responses in mice. PLoS One, 7, 2012, e47748.
25 Boyman, O., Kovar, M., Rubinstein, M.P., Surh, C.D., Sprent, J., Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311 (2006), 1924–1927.
26 Baud, O., Goulet, O., Canioni, D., Le Deist, F., Radford, I., Rieu, D., et al. Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N Engl J Med 344 (2001), 1758–1762.
27 Srivastava, S., Koch, M.A., Pepper, M., Campbell, D.J., Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection. J Exp Med 211 (2014), 961–974.
28 Benson, A., Murray, S., Divakar, P., Burnaevskiy, N., Pifer, R., Forman, J., et al. Microbial infection-induced expansion of effector T cells overcomes the suppressive effects of regulatory T cells via an IL-2 deprivation mechanism. J Immunol 188 (2012), 800–810.
29 Oldenhove, G., Bouladoux, N., Wohlfert, E.A., Hall, J.A., Chou, D., Dos Santos, L., et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31 (2009), 772–786.
30 Boyman, O., Sprent, J., The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol 12 (2006), 180–190.
31 Kastenmuller, W., Gasteiger, G., Subramanian, N., Sparwasser, T., Busch, D.H., Belkaid, Y., et al. Regulatory T cells selectively control CD8+ T cell effector pool size via IL-2 restriction. J Immunol 187 (2011), 3186–3197.
32 Pipkin, M.E., Sacks, J.A., Cruz-Guilloty, F., Lichtenheld, M.G., Bevan, M.J., Rao, A., Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 32 (2010), 79–90.
33 Lackner, H., Urban, C., Sovinz, P., Benesch, M., Moser, A., Schwinger, W., Hemophagocytic lymphohistiocytosis as severe adverse event of antineoplastic treatment in children. Haematologica 93 (2008), 291–294.
34 Olin, R.L., Nichols, K.E., Naghashpour, M., Wasik, M., Shelly, B., Stadtmauer, E.A., et al. Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis. Am J Hematol 83 (2008), 747–749.
35 Tomaske, M., Amon, O., Bosk, A., Handgretinger, R., Schneider, E.M., Niethammer, D., Alpha-CD25 antibody treatment in a child with hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 38 (2002), 141–142.
36 Macian, F., NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 5 (2005), 472–484.